Sumitomo Mitsui Trust Group Inc. increased its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD – Free Report) by 1.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 48,216 shares of the medical instruments supplier’s stock after buying an additional 698 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned 0.23% of Mettler-Toledo International worth $72,310,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also recently bought and sold shares of the business. Family Firm Inc. purchased a new position in Mettler-Toledo International during the 2nd quarter valued at about $25,000. Blue Trust Inc. grew its position in Mettler-Toledo International by 242.9% during the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 17 shares in the last quarter. Ashton Thomas Securities LLC acquired a new position in Mettler-Toledo International in the 3rd quarter valued at approximately $37,000. Rothschild Investment LLC purchased a new stake in Mettler-Toledo International in the 2nd quarter worth approximately $42,000. Finally, Itau Unibanco Holding S.A. acquired a new stake in shares of Mettler-Toledo International during the 2nd quarter valued at $42,000. 95.07% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
MTD has been the subject of several recent research reports. JPMorgan Chase & Co. increased their price objective on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a report on Monday, August 5th. Wells Fargo & Company decreased their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a report on Monday. Evercore ISI raised their price objective on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. Robert W. Baird decreased their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday. Finally, Stifel Nicolaus dropped their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $1,338.75.
Insider Buying and Selling at Mettler-Toledo International
In other news, Director Elisha W. Finney sold 76 shares of the firm’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the sale, the director now owns 240 shares of the company’s stock, valued at approximately $314,820. This trade represents a 24.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 1.94% of the company’s stock.
Mettler-Toledo International Stock Down 1.6 %
NYSE MTD opened at $1,239.13 on Friday. Mettler-Toledo International Inc. has a twelve month low of $1,039.01 and a twelve month high of $1,546.93. The stock has a market cap of $26.15 billion, a P/E ratio of 33.94, a PEG ratio of 4.16 and a beta of 1.16. The company’s 50-day simple moving average is $1,388.91 and its 200 day simple moving average is $1,401.80.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The company had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. Research analysts anticipate that Mettler-Toledo International Inc. will post 40.37 earnings per share for the current year.
About Mettler-Toledo International
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Further Reading
- Five stocks we like better than Mettler-Toledo International
- Consumer Staples Stocks, Explained
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- What Is WallStreetBets and What Stocks Are They Targeting?
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- What is a Dividend King?
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.